|
Adler MW, Geller EB, Rosow CE, Cochin J. The opioid system and temperature regulation. Ann Rev Pharmacol Toxicol 1988; 18: 429-449. Alarcon S, Hernandez J, Laorden ML. Effects of morphine: an electrophysiological study on guinea-pig papillary muscle. J Pharm Pharmacol 1992; 44: 275-277. Apkon M, Nerbonne JM, Characterization of two distinct depolarization-activated K+ currents in isolated adult rat ventricular myocytes. J Gen Physiol 1991; 97: 973-1011. Atweth SF, Kuhar MJ. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 1977; 124: 53-67. Barron BA, Gu H, Gaugl JF, Caffrey JL. Screening for opioids in dog heart. J Mol Cell Cardiol 1992; 24: 67-77. Bean BP. Two kinds of calcium channels in canine atrial cells: Differences in kinetics, selectivity and pharmacology. J Gen Physiol 1985; 86: 1-31. Bell C. Differential effects of tetrodotoxin on sympathomimetic actions of nicotine and tyramine. Br J Pharmacol 1968; 32: 96-103. Benthuysen JL, Smith NT, Sanford TJ, Head N, Dec-Silver H. Physiology of alfentanil-induced rigidly. Anesthesiology 1986; 64: 440-446. Bergey JL, Beil ME. Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pig. Eur J Pharmacol 1983; 90: 427-431. Bian JS, Zhang WM, Xia Q, Wong TM. Phospholipase C inhibitors attenuate arrhythmias induced by k-receptor stimulation in isolated ret heart. J Mol Cell Cardiol 1998; 30: 2103-2110. Blinks JR. Field stimulation as a means of effecting the graded release of autonomic transmitters in isolated heart muscle. J Pharmacol Exp Ther 1966; 151: 221-235. Bollolli R. Mechanism of myocardial "stunning". Circulation 1990; 82: 723-738. Boluyt MO, Younes A, Caffrey JL, O''Neill L, Barron BA, Crow MT, Lakatta EG. Age-associated increase in rat cardiac opioid production. Am J Physiol 1993; 265: H212-H218. Brasch H. Influence of the optical isomers (+)- and (-)-naloxone on beating frequency, contractile force and action potentials of guinea-pig isolated cardiac preparations. Br J Pharmacol 1986; 88: 733-740. Braunwald E, Kloner RA. The stunned myocardium-prolonged post-ischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149. Caffrey JL, Boluyt MO, Younes A, Barron BA, O''Neill L, Crow MT, Lakatta EG. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the fisher 344 rat. J Mol Cell Cardiol 1994; 26: 701-711. Callahan P, Pasternak GW. Opiates, opioid peptides and their receptors. J Cardiothorac Anesth 1987; 1: 569-576. Carmeliet E, Saikawa T. Shortening of the action potential and reduction of pacemaker activity by lidocaine, quinidine, and procainamide in sheep cardiac purkinje fibers. Circ Res 1982; 50: 257-272. Carmeliet E. Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992; 262: 809-817. Carratu, MR, Mitolo-Chieppa D. Inhibition of ionic currents in frog node of Ranvier treated with naloxone. Br J Pharmacol 1982; 77: 115-119. Cerbai E, Cavalcabo PDB, Masini I, Porciatti F, Mugelli A. Antiarrhythmic properties of naloxone : an electrophysiological study on sheep cardiac Purkinje fibers. Eur J Pharmacol 1989; 162: 491-500. Chi JF, Chu SH, Lee CS, Chou NK, Su MJ. Mechanical and electrophysiological effects of 8-oxoberberine (JKL 1073A) on atrial tissue. Br J Pharmacol 1996; 118: 503-512. Clarkson CW, Follmer CH, Ten Eick RE, Hondeghem LM, Yeh JZ. Evidence for two component of sodium channel block by lidocaine in isolated cardiac myocytes. Circ Res 1988; 63: 869-878. Cohen CJ, Bean BP, Tsien RW. Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers. Circ Res 1984; 54: 636-651. Colatsky TJ, Follmer CH, Starmer CF. Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 1990; 82: 2235-2242. Colatsky TJ. Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers. An effect on steady state sodium currents? Circ Res 1982; 50: 17-27. Cooper DMF, Mons M, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signaling. Nature 1995; 373: 421-424. Coraboeuf E, and Carmeliet E. Existence of two transient outward currents in sheep Purkinje fibers. Pflugers Arch 1982; 392: 352-359. Curtis MJ, Hearse DJ. Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 1989; 21: 21-40. DiFrancesco DA, Ferroni M, Mazzanti M, Tromba C. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 1993; 55, 455-472. Dirksen R, Otten, MH, Wood GJ, Verbaan CJ, Haalebos MM, Verdouw PV, Nijhuis GMN. Naloxone in shock . Lancet 1980; 2: 1360. Du XY, Schoemaker RG, Bos E, Saxena PR. Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur J Pharmacol 1994; 259: 173-180. Dukes ID, Cleemann L, Morad M. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cell. J Pharmacol Exp Ther 1990; 254: 560-569. Dukes ID, Morad M. Tedisamil inactivates transient and delayed rectifier K+ currents in rat ventricular myocytes. Am J Physiol 1989; 257: H1746-H1749. Dumont M, Oullette M, Brakier-Gingras L, Lemaire S. Circadian regulation of the biosynthesis of cardiac Met-enkephalin and precursors in normotensive and spontaneously hypertensive rat. Life Sci 1991; 48: 1895-1902. Eisner DA, Lederer WT. Na-Ca exchange: Stoichiometry and electrogenicity. Am J Physiol 1985; 248:Cl89-C202. Escande D, Coulombe A, Faivre, JF, Deroubaix E, Coraboeuf E. Two types of transient outward currents in adult human atrial cells. Am J Physiol 1987; 252: H142-H148. Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science (Wash. DC) 1992; 258: 1039-1044. Faden AI. Role of endogenous opioids in central cardiaovascular regulation and dysregulation. In: A Herz (ed.) Opioid II (Handbook of experimental pharmacology series, vol 104). Springer, Berlin Heidelberg New York, 1993, pp. 191-204. Faden, AI, Holaday JW. Opiate antagonists a role in the treatment of hypovolemic shock. Science 1979; 250: 317-318. Fagbemi O, Lepran I, Parratt JR, Szekeres L. Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol 1982; 76: 504-506. Fermini B, Wang Z, Duan DY, Nattlel S. Differences in the rate dependence of the transient outward current in rabbit and human atrium. Am J Physiol 1992; 263: H1747-H1745. Ferrier GR, Moffat MP, Lukas A. Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion: studies on isolated canine ventricular tissues. Circ Res 1985; 56: 184-194. Feuertein G, Siren A-L. The opioid system in cardiac and vascular regulation of normal and hypertensive states. Circulation 1987; 75 Suppl I: 1125-1129. Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66: 723-730. Frame LH, Argentieri TM. Naloxone has local anesthetic effects on canine cardiac Purkinje fibers. Circulation 1985; 72 Suppl III: 234. Frazier DT, Ohta M, Marahashi T. Nature of the morphine receptor present in the squid axon. Proc Soc Exp Biol Med 1973; 142: 1209-1214. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ. Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res 1999; 84: 846-851. Fuder H, Buder M, Riers HD, Rothacher G. On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro. Naunyn-Schmiedeberg''s Arch Pharmacol 1986; 322: 148-155. Gautret B. Schmitt H. Multiple sites for the cardiovascular actions of fentanyl in rats. J Cardiovasc Pharmacol 1985; 7: 649-652. Giles WR. Imaizumi Y. Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol (Lond) 1988; 405:123-145. Gurney AM. Molecular pharmacology of ion channels using the patch clamp. In EC Hulme (eds.): Receptor-Effector Coupling. A Practical Approach, IRL Press, 1990, pp. 155-179. Gwathmey JK, Haijjar RJ. Effect of protein kinase C activation on sarcoplasmic reticulum function and apparent myofibrillar Ca2+ sensitivity in intact and skinned muscles from normal and diease human myocardium. Circ Res 1990; 67: 744-752. Hagiwara NH, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Phsiol (Lond) 1988; 395: 233-253. Hagiwara NH, Irisawa H, Kasanuki H, Hosoda S. Background current in sino-atrial node cells of the rabbit heart. J Physiol (Lond) 1992; 448: 53-72. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch clamp techniques for high resolution current recording from cells and cell-free membrane patchs. Pflugers Arch 1981; 391: 85-100. Hantson P, Evenepoel M, Ziade D, Hassoun A, Mahieu P. Adverse cardiac manifestations following dextropropoxyphene overdose: Can naloxone be helpful? Ann Emerg Med 1995; 25: 263-266. Harrison C, Smart D, Lambert DG. Stimulatory effects of opioids. Br J Anaesth 1998; 81: 20-28. Harrison DC. Is there a relational basis for the modified classification of antiarrhythmic drugs? In J Morganroth, EN Moore (eds.): New Drugs and Devises. Boston, MA, Martinus Nijhoff, 1985, pp. 36-40. Hirano Y, Hiraoka M. Barium-induced automatic activity in isolated ventricular myocytes from guinea pig hearts. J Physiol (Lond) 1988; 395: 455-472 Hiraoka M, Kawano S. Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J Physiol (Lond) 1989; 410: 187-212. Holaday JW, Faden AI. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Res 1980; 189: 295-299. Holaday JW, Faden AI. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 1978; 275: 450-451. Holaday JW. Cardiovascular effects of endogenous opiate systems. Ann Rev Pharmacol Toxicol 1983; 23: 541-594. Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, Ruf T, Fasol R, Just H: Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 1993; 88: 1228-1237. Hong SJ, Chang CC. Calcium channel subtypes for the sympathetic and parasympathetic nerves of guinea-pig atria. Br J Pharmacol 1995; 116 : 1577-1582. Howells RD, Kilpatrick DL, Bailey LC, Noe M, Udenfriend S. Preproenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 1986; 83: 1960-1963. Huang XD, Lee AYS, Wong TM, Zhan CY, Zhao YY. Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs. Br J Pharmacol 1986; 87: 475-477. Hughes J, Kosterlitz HW, Smith TW. Distribution of methionine-enkephalin and leucine enkephalin in the brain and peripheral tissues, Br J Pharmacol 1977; 62: 639-647. Hughes J. Peripheral opiate receptor mechanisms. Trends Pharmacol Sci 1981; 2: 21-24. Hume JR, Uehara A. Ionic basis of the different action potential configurations of single guinea pig atrial and ventricular myocytes. J Physiol 1985; 368: 525-544. Hurle MA, Mediavillo A, Florez J. Differential respiratory patterns induced by opiois applied to the ventral medullary and dorsal pontine surfaces of cats. Neuropharmacology 1985; 24: 597-606. Hutter OF, Noble D. Rectifying properties of heart muscle. Nature 1960; 188: 495. Isenberg G, Klockner. Calcium tolerant ventricular myocytes prepared by preincubation in a KB-medium. Pflugers Arch 1982; 394: 6-18. Isenberg G. Cardiac Purkinje fibers: cesium as a tool to block inward rectifying potassium currents. Pflugers Arch 1976; 365: 99-106. Jahnel U, Klemm, P, Nawrath H. Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes. Naunyn-Schmiedeberg''s Arch Pharmacol 1994; 349: 87-94. Jahnel U, Rupp J, Ertl R, Nawrath H. Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn-Schmiedeberg''s Arch Pharmacol 1992; 346: 482-485. Jakob H, Nawrath H. Tetrodotoxin slightly shortens action potential duration in ventricular but not in atrial heart muscle. Experientia 1988; 44: 16-17. Jia H, Furukawa T, Singer DH, Sakakibara Y, Eager S, Backer C. Characteristics of lidocaine block of sodium channels in single human atrial cells. J Pharmacol Exp Ther 1993; 264: 1275-1284. Josephson IR, Sanchez-Chapula J, Brown AM. Early outward current in rat single ventricular cells. Circ Res 1984; 54: 157-162. Ju YK, Saint DA, Gage PW. Effects of lignocaine and quinidine on the persistent sodium current in rat ventricular myocytes. Br J Pharmacol 1992; 107: 311-316. Kanemasa T, Asakura K, Ninomiya M. k-opioid agonist U50488 inhibits P-type Ca2+ channels by two mechanisms. Brain Res 1995; 702: 207-212. Kaschube M., Brasch H. Negative chronotropic but no antiarrhythmic effect of (+)- and (-)- naloxone in rats and guinea pigs. Cardiovasc Res 1991; 25: 230-234. Kass RS, Sanguinetti MC. Inactivation of calcium channel current in calf cardiac Purkinje fiber. Evidence for voltage- and calcium-mediated mechanisms. J Gen Physiol 1984; 84: 705-726. Katz RI, Kopin IJ. Electrical field-stimulated release of epinephrine-H3 from rat atrium: effects of ions and drugs, J Pharmacol Exp Ther 1969; 169: 229-236. Kenyon JL, Gibbons WR. Influence of chloride, potassium, and tetraethylamonium on the early outward current of sheep cardiac Purkinje fibers. J Gen Physiol 1979; 73: 117-138. Kieffer B, Befort K, Gaveriaux-Ruff C, Hirth CG. The delta opioid receptor: isolation of a cDNA by expression clonining and pharmacological characterization. Proc Natl Acad Sci USA 1992; 89: 12048-12052. Kieffer BL. Molecular aspect of opioid receptors. In: A Dickenson, JM Besson (eds.): The Pharmacology of Pain. Berlin Heidelberg: Springer-Verlag, 1997, pp. 281-304. Kieffer BL. Opioids: first lessons from knockout mice. Trend Pharmacol Sci 1999; 20: 19-26. Kieffer BL. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 1995; 15: 615-635. Kojima M, Hamamoto T, Ban T. Sodium channel-blocking properties of flecainide, a class Ic antiarrhythmic drug in guinea pig papillary muscles. An open channel blocker or an inactivated channel blocker. Naunyn-Schmiedeberg''s Arch Pharmacol 1989; 399: 441-447. Kosterlitz HW, Taylor DW. The effect of morphine on vagal inhibition of the heart. Br J Pharmacol 1959; 14: 209-214. Koumi S, Sato R, Katori R, Hisatome I, Nagasawa K, Hajakawa H. Sodium channel states control binding and unbinding behavior of antiarrhythmic drugs in cardiac myocytes from the guinea pig. Cardiovasc Res 1992; 26: 1199-1205 Koumi SK, Backer CL, Arentzen CE. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Circulation 1995; 92: 164-174. Lambert DG. Recent advances in opioid pharmacology. Br J Anaesth 1998; 81: 3-7. Lang RE, Hermann K, Dietz R, Gaida W, Ganten D, Kraft K, Unger T. Evidence for the presence oof enkephalins in the heart. Life Sci 1983; 32: 399-406. Langenfeld H, Weirich J, Kohler C, Kochsiek K. Comparative analysis of the action of class I antiarrhythmic drugs (lidocaine, quinidine, and prajmaline) in rabbit atrial and ventricular myocardium. J Cardiovasc Pharmacol 1990; 15: 338-345. Laorden ML, Hernandez J, Caceles MD, Miralles FS, Puig MM. Interaction between halothane and morphine on isolated heart muscle. Eur J Pharmacol 1990; 175: 285-290. Laubie M, Schmitt H Drouillat M. Central sites and mechanisms of hypotensive and bradycardic effects of the narcotic analgesic agent fentanyl. Naunyn-Schmiedeberg''s Arch Pharmacol 1977a; 296: 255-261. Laubie M, Schmitt H, Vincent M, Remond G. Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol 1977b; 46: 67-71. Ledda F, Mantelli L, Corti V, Fantozzi R. Inhibition of the cardiac response to sympathetic nerve stimulation by opioid peptides and its potentiation by morphine and methadone. Eur J Pharmacol 1984; 102: 443-450. Lee KS, Hume JR, Giles W, Brown AM. Sodium current depression by lidocaine and quinidine in isolated ventricular cells. Nature 1981; 291: 325-327. Litovsky SH, Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res 1988; 62: 116-126. Llobel F, Laorden ML. Effects of morphine on atrial preparations obtained from non-failing and failing human hearts. Br J Anaesth 1996; 76: 106-110. Lubbe WF, Bricknell OL, Marzagao C. Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: A mode for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res 1978; 12: 212-220. Manson JW, Hondeghem LM, Katzung BC. Amiodarone blocks inactivated cardiac sodium channels. Pflugers Arch 1983; 396: 79-81. Markiewicz K, Kus W, Cholewa M, Bubinski R. Electrophysiologic effects of blocking and stimulating the opioid system in patients with unexplained heart palpitations. Clin Cardiol 1991; 14: 813. Matuda H. Open state substructure of inwardly rectifying potassium channels revealed by magnesium block in guinea pig heart cells. J Physiol (LOND) 1988; 397: 237-258. Maxwell RJ, Lip YH. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997; 58: 95-117. Medgett IC, McCulloch MW, Rand MJ. Partial agonist action of clonidine on prejunctional and postjunctional a-adrenoceptors. Naunyn-Schmiedeberg''s Arch Pharmacol 1978; 304: 215-221. Micol JA, Laorden ML. Effects of m-, d- and k-agonists on isolated right atria of the rat. Neuropeptides 1994; 26: 365-370. Micol JA, Laorden ML. Interaction between halothane and mu, delta and kappa opioid agonists on the isolated right atria of the rat. Br J Anaesth 1992; 69: 487-491. Micol JA, Laorden ML. Involvement of catecholamines in the effect of U-50,488H on isolated left atria of the rat. Gen Pharmacol 1993; 24: 873-875. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186: 3-12. Mitra R, Morad M. A reliable method for dissociation of myocytes from heart and stomach of vertebrates. Am J Physiol 1985; 18: H1056-H1060. Mohrman DE, Heller LJ. Charcteristics of cardiac cells. In DE Mohrman, LJ Heller (eds.): Cardiovascular physiology. McGraw-Hill Press, 1997, pp. 21-46. Moote CA, Knill RL, Skinner RN, Rose EA. Morphine produces a dose dependent respiratory depression which is potentiated by nonREM sleep. Anesth Analg 1989; 68: S201. Morad M, Goldman Y. Excitation-contraction coupling in heart muscle: membrane control of development of tension. Prog Biophys Mol Biol 1973; 27: 257-313. Murat I, Levron JC, Berg A, Saint-Maurice C. Effects of fentanyl on baroreceptor reflex control of heart rate in newborn infants. Anesthesiology 1988; 68: 717-722. Musha T, Satoh E, Koyanagawa H, Kimura T, Satoh S. Effects opioid agonists on sympathetic and parasympathetic transmission to the dog heart. J Pharmacol Exp Ther 1989; 250: 1087-1091. Neer EJ. Heterotrimeric G-proteins-organizers of transmembrane signals. Cell 1995; 80: 249-257. Nilius B, Hess P, Lansman JB, Tsien RW. A novel type of cardiac calcium channel in ventricular cells. Nature (Lond) 1985; 316: 443-446. Niroomand F, Mura RA, Piacentini L, Kubler W. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma. Naunyn-Schmiedeberg''s Arch Pharmacol 1996; 354: 643-649. Noble D, Tsien RW. The kinetics and rectifier properties of slow potassium current in cardiac Purkinje fibers. J Physiol (Lond) 1968; 195: 185-214. Oldroyd KG, Hicks MN, Cobbe SM. Influence of hyperkalaemia and ischemia on non-receptor-mediated cardiac electrophysiological effects of naloxone. Cardiovasc Res 1993; 27: 296-303. Pancrazio JJ, Frazer MJ, Lynch C. Barbiturate anesthetics depress the resting K+ conductance of myocardium. J Pharmacol Exp Ther.1993; 265: 358-365. Parratt JR, Sitsapesan R. Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischemia. Br J Pharmacol 1986; 87: 621-622. Pasqualucc V, Moricca G, Solinas P. Intrathecal morphine for the control of the pain of myocardial infarction. Anaesthesia 1981; 36: 68-69. Patel S, Patel U, Vithalani D, Verma SC. Regulation of catecholamine release by presynaptic receptor system. Gen Pharmacol 1981; 12: 405-422. Paterson SJ, Robson LE, Kasterlitz HW. Classification of opioid receptors. Br Med Bull 1983; 39: 31-36. Pepe S, Xiao RP, Hohl C, Altschuld R, Lakatta EG. '' Cross talk'' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 1997; 95: 2122-2129. Peters WP, Johnson MW, Friedman PA, Mitch WE. Pressor effect of naloxone in septic shock. Lancet 1981; 1: 529-532. Pogwizd S, Corr PB. Electrophysiological mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium. Circulation 1987; 56: 184-194. Pugsley MK, Penz, WP, Walker MJA, Wong TM. Cardiovascular actions of k-agonist, U-50,488H in the absence and presence of opioid receptor blockade. Br J Pharmacol 1992; 105: 521-526. Pugsley MK, Saint DA, Penz MP, Walker MJ. Elecrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R, R (+)-enantiomer, PD 129289. Br J Pharmacol 1993; 110: 1579-1585. Pugsley MK, Saint DA, Walker MJA. An electrophysiological basis for the antiarrhythmic actions of the k-opioid receptor agonist U-50,488H. Eur J Pharmacol 1994; 261: 303-309. Rabkin SW. Morphine and morphicetin increase the threshold for epinephrine-induced cardiac arrhythmias in the rat through mu opioid receptors. Clin Exp Physiol 1993; 20: 95-102. Rees S, Pabla R, Pugsley MK, Banner K, Curtis MJ. Drugs and the cardiovascular system. In CP Page, MJ Curtis, MC Sutter, MJA Walker, BB Hoffman (eds.): Integrated Pharmacology. Mosby Press, 1997, pp. 158-164. Reisine T, Bell GL. Molecular biology of opioid receptors. Trends Neurosci 1993; 16: 506-510. Roden DM, George ALJr. The cardiac ion channels: relevance to management of arrhythmias. Annu Rev Med 1996; 47: 135-148. Rogers TB, Gaa ST, Massey C. Dosemeci A. Protein kinase C inhibits Ca2+ accumulation in cardiac sarcoplasmic reticulum. J Biol Chem 1990; 265: 4302-4308. Rosow CE, Philbin DM, Keegan CR, Moss J. hemodynamics and histamine release during induction with sufentanil or fentanyl. Anesthesiology 1984; 60: 489-491. Saeki T, Nishimura M, Sato N, Fujinami T, Watanabe Y. Electrophysiological demonstration and activation of m-opioid receptors in the rabbit sinoatrial node. J Cardiovasc Pharmacol 1995; 26: 160-168. Sagy, M, Shavit G, Oron Y,Vidne BA, Gitter S, Sarne Y. Nonopiate effect of naloxone on cardiac muscle contractility. J Cardiaovasc Pharmacol 1987; 9: 682-685. Sanchez-Chapula J, Tsuda Y, Joephson IR. Voltage and use-dependent effect of lidocaine on sodium current in single ventricular cell. Circ Res 1983; 52: 557-565. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. J Gen Physiol 1990; 96: 195-215. Sanguinetti MC, Siegl PKS. Control of cardiac contractility by K+ channel modulators; in JK Gwathmey (ed.): Heart Failure: Basic Science and Clinical Aspects. New York, Marcel Dekker, 1993, pp. 613-627. Sarne Y, Flitstein A, Oppenheimer E. Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers. Br J Pharmacol 1991; 102: 696-698. Sarne Y, Hochman I, Eshed, M, Oppenheimer E. Antiarrhythmic action of naloxone: direct, non-opiate effect on the rat heart. Life Sci 1988 43: 859-864. Satoh M, Minami M. Molecular pharmacology of the opioid receptors. Pharmacol Ther 1995; 68: 343-364. Saxena PR, Villalon CM, Dhasmana KM, Verdouw PD. 5-hydroxytryptamine-induced increase in left ventricular dP/dtmax does not suggest the presence of ventricular 5-HT4 receptors in the pig. Naunyn-Schmiedeberg''s Arch Pharmacol 1992; 346: 629-636. Schoemaker RG, Du XY, Bax WA, Bos E, Saxena PR. 5-hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol 1993; 230: 103-105. Schoemaker RG, Du XY, Bax WA, Saxena PR. 5-hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle. Naunyn-Schmiedeberg''s Arch Pharmacol 1992; 346: 486-489. Schultz JE, Hsu AK, Cross GJ. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 1998; 97: 1282-1289. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via the glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-1104. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995; 268: H2157-H2161. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997a; 29: 2187-2195. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol 1997b; 29: 1355-1362. Scott BH. Opioids in cardiac surgery: Cardiopulmonary bypass and inflammatory response. Int J Cardiol 1998; 64 Suppl. 1: S35-S41. Sheng JZ, Wong TM. Chronic U50,488H abolishes inositol 1,4,5-triphosphate and intracellular Ca2+ elevations evoked by k-opioid receptor in rat myocytes. Eur J Pharmacol 1996; 307: 323-329. Sheu SS, Fozzard HA. Transmembrane Na+ and Ca2+ electrochemical gradients in cardiac muscle and their relationship to force development. J Gen Physiol 1982; 80: 325-351. Sheu SS, Lederer WJ. Lidocaine''s negative inotropic and antiarrhythmic action. Circ Res 1985; 57: 578-590. Singh BN, Hauswirth O. Comparative mechanisms of action of antiarrhythmic drug. Am Heart J 1974; 87: 367-382. Singh BN, Vaughan Williams EM. Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ Res 1971; 29: 286-295. Sitsapesan R, Parrat JR. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br J Pharmacol 1989; 97: 795-800. Slawsky MT, Castle NA. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther 1994; 269: 66-74. Springhorn JP, Clay WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 1989; 258: 73-78. Stark K, Schoffel E, Illes P. The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid k- but not m- or d- receptors. Naunyn-Schmiedeberg''s Arch Pharmacol 1985; 329: 206-209. Starke K. Presynaptic receptors. Ann Rev Pharmacol Toxicol 1981; 21: 7-30. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS. Presence of m3 opiate receptor in endothelial cell: coupling to nitric oxide production and vasodilation. J Biol Chem 1995; 270: 30290-30293. Su MJ, Chang YM, Chi JF, Lee SS. Thaliporphine, a positive inotropic agent with a negative chronotropic action. Eur J Pharmacol 1994; 254: 141-150. Su MJ, Lin SO, Wang CH, Tseng YZ, Tseng CD. Comparison of the electrophysiological effect of amiodarone, lidocaine and quinidne on rat ventricular cells. Proc Natl Sci Counc (ROC) 1990; 14: 105-113. Tai KK, Bian CF, Wong TM. k-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci 1992; 51: 909-913. Tai KK, Jin WQ, Chan TKY, Wong TM. Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol 1991; 23: 1297-1302. Tang J, Yang HYT, Costa E. Distribution of met-enkephalin-arg6-phe7 in various tissues of rats and guinea pigs. Neuropharmacology 1982; 21: 595-600 Tseng G-N, Hoffman BF. Two components of transient outward current in canine ventricular myocytes. Circ Res 1989; 64:633-647. Tsuchida A, Miura T, Tanno M, Nozawa Y, Kita H, Shimamoto K. Time window for the contribution of the delta-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart. Cardiovasc Drugs Ther 1998; 12: 365-373. Ulett GA, Han S, Han JS. Electoacupuncture: mechanisms and clinical application. Biol Psychiatry 1998; 44:129-138. Utz J, Eckert R, Trautwein W. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the k-opioid agonist U50488H does not involve binding to opiate receptor. J Pharmacol Exp Ther 1995; 274: 627-633. Vahlensieck U, Boknik P, Gombosova I, Huke S, Knapp J, Linck B, Lub H, Muller FU, Neumann J, Neng MC, Scheld HH, Jankowski H, Schluter H, Zimmermann N, Schmitz W. Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 1999; 288: 805-813. Vargish T, Reynolds DG, Gurll NJ, Lechner RB, Holaday JW, Faden AI. Naloxone reversal of hypovolemic shock in dogs. Circ Shock 1980; 7: 31-38. Varon J, Duncan SR. Naloxone reversal of hypotension due to captopril overdose. Ann Emerg Med 1991; 20: 1125-1127. Vaughan Williams EM. Classification of antiarrhythmic drugs. In E Sandoe. E Flensted-Jensen, EH Olsen (eds.): Symposium on Cardiac Arrhythmias. Denmark: Astra, 1970, pp. 449-501. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 1989; 987: 69-74. Ventura C, Capogrossi MC. k-opioid peptide receptor stimulation increase cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes. Am J Physiol 1991; 261: H1671-1674. Ventura C, Guarnieri C, Vaona I, Campana G, Pintus G, Spampinato S. Dynorphin gene express and release in the myocardial cell. J Biol Chem 1994; 269: 5384-5386. Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, Capogrossi MC. k and d opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ Res 1992; 70: 66-81. Vismara LA, Leaman DL, Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976; 54: 335-337. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 1993; 73: 276-285. Wang Z, Fermini B, Nattel S. Mechanism of flecainides rate-dependent actions on action potential duration in canine atrial tissues. J Pharmacol Exp Ther 1993; 267, 575-581. Wasserstrom JA, Salata JJ. Basis for tetrodotoxin and lidocaine effects on action potentials in dog ventricular myocytes. Am J Physiol 1988; 254: H1157-Hll66. Weihe E, McKnight AT, Corbett AD, Kosterlitz HW. Proenkephalin- and prodynorphin-deived opioid peptides in guinea-pig heart and skin. Neuropeptides 1985; 5: 453-456. Weitzellet R, Illes P, Starke K. Inhibition via opioid m- and d-receptors of vagal transmission in rabbit isolated heart. Naunyn-Schmiedeberg''s Arch Pharmacol 1984; 328: 186-190. Wenzlaff H, Weil G, Stein B, Teschemacher H. Negative inotropic effects of opioid receptor agonists in isolated rat ventricular cardiomyocytes mediated via k opioid receptors are sensitive to pertussis toxin, Naunyn-Schmiedeberg''s Arch Pharmacol 1998; 358: 360-366. Wettwer E, Amos G, Gath J, Zerkowski HR, Reidemeister JC, Ravens U. Transient outward current in human and rat ventricular myocytes. Cardiovasc Res 1993; 27: 1662-1669. Winslow E. Methods for the detection and assessment of antiarrhythmic activity. Pharmacol Ther 1984; 124: 401-433. Wong TM, Lee AYS, Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart-an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 1990; 22: 1167-1175. Wong TM, Sheng JZ, Wong NS, Tai KK. Signal transduction in the cardiac k-receptor. Biol Signals 1995; 4: 174-178. Wong-Dusting H K, Rand MJ. Effect of [D-Ala2, Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria. Eur J Pharmacol 1985; 111: 65-72. Wong-Dusting H K, Rand MJ. Effects of the opioid peptides [Met5]enkephalin-Arg6-Gly7-Leu8 on cholinergic neurotransmission in the rabbit isolated atria. Clin Exp Pharmacol Physiol 1987; 14: 725-730. Wu MH, Su MJ, Lee SS, Young ML. The electrophysiological effects of antiarrhythmic potential of a secoaporphine, N-allylsecoboldine. Br J Pharmacol 1994; 113: 221-227. Xia Q, Sheng JZ, Tai KK, Wong TM. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts. J Pharmacol Exp Ther 1994; 268: 930-934. Xiao RP, Pepe S, Spurgeon HA, Capogrossi MC, Lakatta EG. Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells. Am J Physiol 1997; 272: H797-805. Xiao RP, Spurgeon HA, Capogrossi, MC, and Lakatta, EG. Stimulation of opioid receptors on cardiac ventricular myocytes reduces L type Ca2+ channel current. J Mol Cell Cardiol 1993; 25: 661-666. Yu XC, Li HY, Wong HX, Wong TM. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes?cross-talk between k-opioid and b-adrenergic receptors. J Mol Cell Cardiol 1998; 30: 405-413. Yue DT, Marban E. A novel cardiac potassium channel that is active and conductive at depolarized potentials. Pflugers Arch 1988; 413:127-133. Zygmunt AC, Gibbons WR. Calcium-activated chloride current in rabbit ventricular myocytes. Circ Res 1991; 68:424-437.
|